Bristol-Myers Squibb
BMY
BMY
1,775 hedge funds and large institutions have $60.3B invested in Bristol-Myers Squibb in 2019 Q2 according to their latest regulatory filings, with 128 funds opening new positions, 728 increasing their positions, 710 reducing their positions, and 135 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
7% less call options, than puts
Call options by funds: $1.24B | Put options by funds: $1.33B
2% less funds holding
Funds holding: 1,811 → 1,775 (-36)
10% less funds holding in top 10
Funds holding in top 10: 42 → 38 (-4)
Holders
1,775
Holding in Top 10
38
Calls
$1.24B
Puts
$1.33B
Top Buyers
| 1 | +$545M | |
| 2 | +$431M | |
| 3 | +$423M | |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
+$408M |
| 5 |
Renaissance Technologies
New York
|
+$379M |
Top Sellers
| 1 | -$542M | |
| 2 | -$529M | |
| 3 | -$241M | |
| 4 |
Millennium Management
New York
|
-$206M |
| 5 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$159M |